Updated on 6 June 2012
The year 2012 is a period of excitement and challenges as the company celebrates its 100th anniversary. The company aims to continue to show its ability to evolve and respond to an ever-changing industry.
"The coming year brings further industry challenges. Major pharmaceutical benefits scheme (PBS) reform measures are expected to slow industry growth over 2012. Our strategic initiatives will continue, which we believe will position the company well for future growth," said Mr Mark Hooper, CEO and managing director, Sigma Pharmaceuticals.
Get direct access to more such reports. Subscribe to BioSpectrum Bureau 
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Send this article by email
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
